[Type the company name]
MNE3702 Assignment 2
(COMPLETE ANSWERS)
Semester 2 2024 (156077) -
DUE 25 September 2024
[Type the document subtitle]
tabbymwesh59@gmail.com
[Year]
, Exam (elaborations)
MNE3702 Assignment 2 (COMPLETE ANSWERS)
Semester 2 2024 (156077) - DUE 25 September 2024
Course
Corporate Entrepreneurship (MNE3702)
Institution
University Of South Africa (Unisa)
Book
Corporate Innovation & Entrepreneurship, International Edition
MNE3702 Assignment 2 (COMPLETE ANSWERS) Semester 2 2024
(156077) - DUE 25 September 2024 ; 100% TRUSTED Complete, trusted
solutions and explanations Ensure your success with us..
Question 1. Discuss the concept entrepreneurial intensity and indicate by
means of examples how it is applied at J&R (12). 3 Question 2: By quoting
relevant issues from the case study, present at least six characteristics
displayed that are associated with an entrepreneurial individual (6) 4 Question
3.1: Identify and explain six(6) ways in which entrepreneurship can be
manifested at J&R (6)6 Question 3.2: Why do you think J&R adopted an open
innovation model? Discuss the reasons why (6). 8 Question 4.1: Roles of
Lower-Level Management (Kabelo's Role) 9 Question 4.2: Technology-Push
vs. Market-Pull Innovation..
Question 1: Discuss the Concept of Entrepreneurial Intensity and Its Application
at J&R
Entrepreneurial Intensity refers to the level of entrepreneurial activity and innovation present
within an organization. It encompasses the degree to which an organization or individual engages
in entrepreneurial behaviors, such as taking risks, seeking new opportunities, and fostering
innovation. Entrepreneurial intensity is often characterized by a high frequency of
entrepreneurial actions and a strong commitment to innovation and growth.
Application at J&R:
1. Innovation Culture:
o Example: At J&R, entrepreneurial intensity might be reflected in a strong culture
of innovation where employees are encouraged to propose new ideas and take
calculated risks. For instance, J&R could have a structured process for idea